- Release Date: 20/04/23 08:13
- Summary: Latest Preclinical HIE Study Results
- Price Sensitive: Yes
- Download Document 460.4KB
- Forums
- ASX - By Stock
- Ann: Latest Preclinical HIE Study Results
AGN
argenica therapeutics limited
Add to My Watchlist
0.00%
!
32.0¢

Ann: Latest Preclinical HIE Study Results
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.10M |
Open | High | Low | Value | Volume |
32.0¢ | 32.0¢ | 31.0¢ | $11.20K | 35.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 278049 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 5444 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 278049 | 0.310 |
2 | 9787 | 0.305 |
3 | 37003 | 0.300 |
1 | 20000 | 0.295 |
2 | 234000 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 5444 | 2 |
0.330 | 20000 | 1 |
0.335 | 56153 | 2 |
0.340 | 11717 | 1 |
0.350 | 94430 | 5 |
Last trade - 11.11am 15/09/2025 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online